Palliative care in neuro-oncology

Home care for brain tumor patients

A. Pace, P. Tisei, A. Zizzari, M. Maschio, A. Pompili, C. M. Carapella, E. Occhipinti, B. Jandolo

Research output: Contribution to journalArticle

Abstract

In the last few years great interest has been generated in the role of home care, especially for cancer patients. The need for care of patients operated for malig- nant brain tumors are not limited to the initial phases of disease but require continuing management of clinical, rehabilitation, and psychosocial problems. In February 1998 we began a comprehensive home care program for patients discharged from our Institution. As of February 2000 100 patients have been included (65 malignant gliomas, 25 astrocytoma low grade and 10 cerebral metastases). To investigate the impact of the disease on patient's quality of life, incidence of neurological symptoms and complicance, psycho-social aspects and costs in terms of hospital readmission after discharge, we applied to the patients the following scales: Barthel Index, Karnofsky Performance Status, Mini Mental Test, Beck Depression Scale. Rehabilitation outcome and modification of patients and caregivers lifestyle were also evaluated. In all, 52 patients with malignant tumors died (82% at home). Incidence of depression in the first 3 months after discharge was 51% in malignant gliomas and 42% in patients with cerebral metastasis. The rate of hospital readmission was 20% in malignant tumors and 28% in patients with metastasis. More frequent complications were epilepsy (18%), thromboembolism (12%), and pneumonia (5%). Better knowledge of the natural course of disease and of potential complications and symptoms experienced by neuro-oncologic patients may enhance their quality of life.

Original languageEnglish
JournalNeurological Sciences
Volume21
Issue number4 SUPPL.
Publication statusPublished - 2000

Fingerprint

Home Care Services
Palliative Care
Brain Neoplasms
Patient Readmission
Neoplasm Metastasis
Glioma
Quality of Life
Depression
Karnofsky Performance Status
Neoplasms
Intelligence Tests
Thromboembolism
Incidence
Astrocytoma
Caregivers
Life Style
Epilepsy
Pneumonia
Patient Care
Costs and Cost Analysis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Palliative care in neuro-oncology : Home care for brain tumor patients. / Pace, A.; Tisei, P.; Zizzari, A.; Maschio, M.; Pompili, A.; Carapella, C. M.; Occhipinti, E.; Jandolo, B.

In: Neurological Sciences, Vol. 21, No. 4 SUPPL., 2000.

Research output: Contribution to journalArticle

Pace, A, Tisei, P, Zizzari, A, Maschio, M, Pompili, A, Carapella, CM, Occhipinti, E & Jandolo, B 2000, 'Palliative care in neuro-oncology: Home care for brain tumor patients', Neurological Sciences, vol. 21, no. 4 SUPPL..
Pace, A. ; Tisei, P. ; Zizzari, A. ; Maschio, M. ; Pompili, A. ; Carapella, C. M. ; Occhipinti, E. ; Jandolo, B. / Palliative care in neuro-oncology : Home care for brain tumor patients. In: Neurological Sciences. 2000 ; Vol. 21, No. 4 SUPPL.
@article{9146c9a48e7a4e4b8e63fe685f5d3d01,
title = "Palliative care in neuro-oncology: Home care for brain tumor patients",
abstract = "In the last few years great interest has been generated in the role of home care, especially for cancer patients. The need for care of patients operated for malig- nant brain tumors are not limited to the initial phases of disease but require continuing management of clinical, rehabilitation, and psychosocial problems. In February 1998 we began a comprehensive home care program for patients discharged from our Institution. As of February 2000 100 patients have been included (65 malignant gliomas, 25 astrocytoma low grade and 10 cerebral metastases). To investigate the impact of the disease on patient's quality of life, incidence of neurological symptoms and complicance, psycho-social aspects and costs in terms of hospital readmission after discharge, we applied to the patients the following scales: Barthel Index, Karnofsky Performance Status, Mini Mental Test, Beck Depression Scale. Rehabilitation outcome and modification of patients and caregivers lifestyle were also evaluated. In all, 52 patients with malignant tumors died (82{\%} at home). Incidence of depression in the first 3 months after discharge was 51{\%} in malignant gliomas and 42{\%} in patients with cerebral metastasis. The rate of hospital readmission was 20{\%} in malignant tumors and 28{\%} in patients with metastasis. More frequent complications were epilepsy (18{\%}), thromboembolism (12{\%}), and pneumonia (5{\%}). Better knowledge of the natural course of disease and of potential complications and symptoms experienced by neuro-oncologic patients may enhance their quality of life.",
author = "A. Pace and P. Tisei and A. Zizzari and M. Maschio and A. Pompili and Carapella, {C. M.} and E. Occhipinti and B. Jandolo",
year = "2000",
language = "English",
volume = "21",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Palliative care in neuro-oncology

T2 - Home care for brain tumor patients

AU - Pace, A.

AU - Tisei, P.

AU - Zizzari, A.

AU - Maschio, M.

AU - Pompili, A.

AU - Carapella, C. M.

AU - Occhipinti, E.

AU - Jandolo, B.

PY - 2000

Y1 - 2000

N2 - In the last few years great interest has been generated in the role of home care, especially for cancer patients. The need for care of patients operated for malig- nant brain tumors are not limited to the initial phases of disease but require continuing management of clinical, rehabilitation, and psychosocial problems. In February 1998 we began a comprehensive home care program for patients discharged from our Institution. As of February 2000 100 patients have been included (65 malignant gliomas, 25 astrocytoma low grade and 10 cerebral metastases). To investigate the impact of the disease on patient's quality of life, incidence of neurological symptoms and complicance, psycho-social aspects and costs in terms of hospital readmission after discharge, we applied to the patients the following scales: Barthel Index, Karnofsky Performance Status, Mini Mental Test, Beck Depression Scale. Rehabilitation outcome and modification of patients and caregivers lifestyle were also evaluated. In all, 52 patients with malignant tumors died (82% at home). Incidence of depression in the first 3 months after discharge was 51% in malignant gliomas and 42% in patients with cerebral metastasis. The rate of hospital readmission was 20% in malignant tumors and 28% in patients with metastasis. More frequent complications were epilepsy (18%), thromboembolism (12%), and pneumonia (5%). Better knowledge of the natural course of disease and of potential complications and symptoms experienced by neuro-oncologic patients may enhance their quality of life.

AB - In the last few years great interest has been generated in the role of home care, especially for cancer patients. The need for care of patients operated for malig- nant brain tumors are not limited to the initial phases of disease but require continuing management of clinical, rehabilitation, and psychosocial problems. In February 1998 we began a comprehensive home care program for patients discharged from our Institution. As of February 2000 100 patients have been included (65 malignant gliomas, 25 astrocytoma low grade and 10 cerebral metastases). To investigate the impact of the disease on patient's quality of life, incidence of neurological symptoms and complicance, psycho-social aspects and costs in terms of hospital readmission after discharge, we applied to the patients the following scales: Barthel Index, Karnofsky Performance Status, Mini Mental Test, Beck Depression Scale. Rehabilitation outcome and modification of patients and caregivers lifestyle were also evaluated. In all, 52 patients with malignant tumors died (82% at home). Incidence of depression in the first 3 months after discharge was 51% in malignant gliomas and 42% in patients with cerebral metastasis. The rate of hospital readmission was 20% in malignant tumors and 28% in patients with metastasis. More frequent complications were epilepsy (18%), thromboembolism (12%), and pneumonia (5%). Better knowledge of the natural course of disease and of potential complications and symptoms experienced by neuro-oncologic patients may enhance their quality of life.

UR - http://www.scopus.com/inward/record.url?scp=33845334238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845334238&partnerID=8YFLogxK

M3 - Article

VL - 21

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 4 SUPPL.

ER -